Cai Wei, Zhang Shui-Li
Department of Chinese Materia Medica, Zhejiang Pharmaceutical University, Ningbo 315100, China.
Zhejiang Chinese Medical University, Hangzhou 310053, China.
Evid Based Complement Alternat Med. 2022 Jun 8;2022:2154485. doi: 10.1155/2022/2154485. eCollection 2022.
Influenza virus is one of the most common infectious pathogens that could cause high morbidity and mortality in humans. However, the occurrence of drug resistance and serious complications extremely complicated the clinic therapy. is a natural medicinal plant used for treating various lung and gastrointestinal diseases, including viral infection, cough, chronic obstructive pulmonary disease, acute gastroenteritis, and diarrhoea. But the therapeutic effects of this herbal medicine had not been expounded clearly. In this study, a network pharmacology approach was employed to investigate the protective mechanism of total flavonoids from (MSTF) against influenza virus- (IAV-) induced acute lung damage and inflammation. The active compounds of MSTF were analyzed by LC-MS/MS and then evaluated according to their oral bioavailability and drug-likeness index. The potential targets of each active compound in MSTF were identified by using PharmMapper Server, whereas the potential genes involved in IAV infection were obtained from GeneGards. The results showed that luteoloside, apigenin, kaempherol, luteolin, mosloflavone I, and mosloflavone II were the main bioactive compounds found in MSTF. Primarily, 23 genes were identified as the targets of those five active compounds, which contributed to the inactivation of chemical carcinogenesis ROS, lipid and atherosclerosis, MAPK signaling pathway, pathways in cancer, PI3K-AKT signaling pathway, proteoglycans in cancer, and viral carcinogenesis. Finally, the animal experiments validated that MSTF improved IAV-induced acute lung inflammation via inhibiting MAPK, PI3K-AKT, and oxidant stress pathways. Therefore, our study demonstrated the potential inhibition of MSTF on viral pneumonia in mice and provided a strategy to characterize the molecular mechanism of traditional Chinese medicine by a combinative method using network pharmacology and experimental validation.
流感病毒是最常见的可导致人类高发病率和死亡率的传染性病原体之一。然而,耐药性的出现和严重并发症使临床治疗极其复杂。[植物名称]是一种天然药用植物,用于治疗各种肺部和胃肠道疾病,包括病毒感染、咳嗽、慢性阻塞性肺疾病、急性胃肠炎和腹泻。但这种草药的治疗效果尚未得到明确阐述。在本研究中,采用网络药理学方法研究[植物名称]总黄酮(MSTF)对甲型流感病毒(IAV)诱导的急性肺损伤和炎症的保护机制。通过LC-MS/MS分析MSTF的活性成分,然后根据其口服生物利用度和类药指数进行评估。利用PharmMapper服务器鉴定MSTF中每种活性成分的潜在靶点,而从GeneGards获得IAV感染涉及的潜在基因。结果表明,木犀草苷、芹菜素、山奈酚、木犀草素、毛蕊黄酮I和毛蕊黄酮II是MSTF中发现的主要生物活性成分。首先,鉴定出23个基因作为这五种活性成分的靶点,这些靶点有助于化学致癌ROS失活、脂质和动脉粥样硬化、MAPK信号通路、癌症相关通路、PI3K-AKT信号通路、癌症中的蛋白聚糖以及病毒致癌。最后,动物实验证实MSTF通过抑制MAPK、PI3K-AKT和氧化应激途径改善IAV诱导的急性肺部炎症。因此,我们的研究证明了MSTF对小鼠病毒性肺炎的潜在抑制作用,并提供了一种通过网络药理学和实验验证相结合的方法来表征中药分子机制的策略。